【4507】塩野義製薬
製薬。感染症、疼痛・中枢神経、抗HIV。
保有者 | 2014.3 | 2014.9 | 2015.3 | 2015.9 | 2016.3 | 2016.9 | 2017.3 | 2017.9 | 2018.3 | 2018.9 | 2019.3 | 2019.9 | 2020.3 | 2020.9 | 2021.3 | 2021.9 | 2022.3 | 2022.9 | 2023.3 | 2023.9 | 2024.3 | 2024.9 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
日本マスタートラスト信託銀行株式会社(信託口) | 23,512,000 (6.69%) |
25,881,000
![]() |
26,827,000
![]() |
28,653,000
![]() |
29,391,000
![]() |
30,854,000
![]() |
30,279,000
![]() |
31,255,000
![]() |
32,435,000
![]() |
34,880,000
![]() |
36,408,000
![]() |
36,498,000
![]() |
38,091,000
![]() |
40,608,000
![]() |
41,349,000
![]() |
55,101,000
![]() |
63,344,000
![]() |
61,221,000
![]() |
57,487,000
![]() |
55,268,000
![]() |
56,082,000
![]() |
53,169,000
![]() |
株式会社日本カストディ銀行 (信託口) | 14,970,000 (4.26%) |
16,302,000
![]() |
16,704,000
![]() |
20,424,000
![]() |
25,264,000
![]() |
22,455,000
![]() |
20,646,000
![]() |
20,345,000
![]() |
20,290,000
![]() |
20,367,000
![]() |
20,200,000
![]() |
19,580,000
![]() |
19,167,000
![]() |
18,860,000
![]() |
18,663,000
![]() |
18,770,000
![]() |
19,271,000
![]() |
23,974,000
![]() |
24,189,000
![]() |
23,600,000
![]() |
23,981,000
![]() |
24,382,000
![]() |
住友生命保険相互会社 | 18,604,000 (5.29%) |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
18,604,000
![]() |
株式会社SMBC信託銀行(株式会社三井住友銀行退職給付信託口) | 9,485,000 (2.7%) |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
9,485,000
![]() |
日本生命保険相互会社 | 9,460,000 (2.69%) |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
8,409,000
![]() |
BANK OF CHINA (HONG KONG) LIMITED-PING AN LIFE INSURANCE COMPANY OF CHINA, LIMITED(常任代理人:シティバンク、エヌ・エイ東京支店) | 6,356,000 (2.04%) |
6,356,000
![]() |
6,356,000
![]() |
6,356,000
![]() |
6,356,000
![]() |
6,356,000
![]() |
6,356,000
![]() |
6,356,000
![]() |
6,356,000
![]() |
|||||||||||||
STATE STREET BANK WEST CLIENT - TREATY 505234(常任代理人株式会社みずほ銀行) | 4,811,000 (1.37%) |
5,021,000
![]() |
4,774,000
![]() |
4,948,000
![]() |
5,757,000
![]() |
4,868,000
![]() |
4,970,000
![]() |
4,979,000
![]() |
4,973,000
![]() |
4,916,000
![]() |
5,023,000
![]() |
5,510,000
![]() |
5,639,000
![]() |
6,183,000
![]() |
||||||||
JPモルガン証券株式会社 | 3,707,000 (1.25%) |
4,453,000
![]() |
4,609,000
![]() |
|||||||||||||||||||
STATE STREET BANK AND TRUST COMPANY 505001(常任代理人 株式会社みずほ銀行) | 11,854,000 (3.76%) |
5,859,000
![]() |
3,913,000
![]() |
|||||||||||||||||||
STATE STREET BANK AND TRUST COMPANY 505103(常任代理人 株式会社みずほ銀行) | 3,367,000 (1.17%) | |||||||||||||||||||||
NORTHERN TRUST CO.(AVFC) SUB A/C AMERICAN CLIENTS(常任代理人:香港上海銀行東京支店カストディ業務部) | 4,820,000 (1.59%) |
4,909,000
![]() |
4,931,000
![]() |
4,587,000
![]() |
4,190,000
![]() |
3,882,000
![]() |
3,650,000
![]() |
|||||||||||||||
JP MORGAN CHASE BANK 385781(常任代理人 (株)みずほ銀行) | 3,430,000 (1.19%) | |||||||||||||||||||||
株式会社三井住友銀行 | 6,564,000 (1.86%) |
6,564,000
![]() |
6,564,000
![]() |
6,564,000
![]() |
6,564,000
![]() |
6,564,000
![]() |
4,595,000
![]() |
4,595,000
![]() |
4,595,000
![]() |
4,595,000
![]() |
4,595,000
![]() |
4,595,000
![]() |
4,595,000
![]() |
|||||||||
JP MORGAN CHASE BANK 385632 (常任代理人 株式会社みずほ銀行) | 6,700,000 (2.2%) |
6,806,000
![]() |
9,287,000
![]() |
9,314,000
![]() |
7,582,000
![]() |
11,056,000
![]() |
4,822,000
![]() |
|||||||||||||||
株式会社日本カストディ銀行(信託口7) | 5,016,000 (1.59%) |
4,638,000
![]() |
5,000,000
![]() |
5,990,000
![]() |
6,955,000
![]() |
8,112,000
![]() |
7,484,000
![]() |
7,108,000
![]() |
||||||||||||||
BNYM TREATY DTT 15 (常任代理人 株式会社三菱UFJ銀行) | 4,689,000 (1.49%) |
7,625,000
![]() |
8,566,000
![]() |
7,131,000
![]() |
6,982,000
![]() |
|||||||||||||||||
株式会社日本カストディ銀行(信託口5) | 4,880,000 (1.48%) |
5,402,000
![]() |
5,467,000
![]() |
5,294,000
![]() |
5,017,000
![]() |
5,122,000
![]() |
5,208,000
![]() |
5,243,000
![]() |
||||||||||||||
株式会社日本カストディ銀行(信託口9) | 5,549,000 (1.76%) |
5,185,000
![]() |
5,148,000
![]() |
|||||||||||||||||||
JP MORGAN CHASE BANK 380055 (常任代理人:株式会社みずほ銀行決済営業部) | 5,647,000 (1.81%) | |||||||||||||||||||||
JP MORGAN CHASE BANK 385147(常任代理人 株式会社みずほ銀行) | 15,935,000 (4.53%) |
17,307,000
![]() |
17,307,000
![]() |
16,638,000
![]() |
16,638,000
![]() |
15,755,000
![]() |
14,932,000
![]() |
14,932,000
![]() |
13,215,000
![]() |
|||||||||||||
塩野義製薬株式会社 | 16,242,000 (4.62%) |
16,230,000
![]() |
25,564,000
![]() |
25,557,000
![]() |
25,559,000
![]() |
25,544,000
![]() |
10,347,000
![]() |
10,322,000
![]() |
||||||||||||||
株式会社スズケン | 4,341,000 (1.23%) |
4,341,000
![]() |
4,341,000
![]() |
4,341,000
![]() |
4,341,000
![]() |
|||||||||||||||||
THE BANK OF NEW YORK MELLON SA/NV 10 (常任代理人 株式会社三菱UFJ銀行) | 4,386,000 (1.24%) |
5,685,000
![]() |
4,264,000
![]() |
|||||||||||||||||||
SSBT OD05 OMNIBUS ACCOUNT-TREATY CLIENTS(常任代理人 香港上海銀行東京支店) | 5,162,000 (1.47%) |
4,628,000
![]() |